Corydalis saxicola Bunting total alkaloids improve NAFLD by suppressing de novo lipogenesis through the AMPK-SREBP1 axis-Reference-Cited by-同舟云学术

Corydalis saxicola Bunting total alkaloids improve NAFLD by suppressing de novo lipogenesis through the AMPK-SREBP1 axis

Published:2024-01 Issue: Volume:319 Page:117162
ISSN:0378-8741
Container-title:Journal of Ethnopharmacology
language:en
Short-container-title:Journal of Ethnopharmacology

Author:

Guo Yating^ORCID,Sun Qiushuang,Wang Shijiao,Zhang Mengdi,Lei Yuanyuan,Wu Jiejie,Wang Xinhong,Hu Wenjun,Meng Haitao,Li Zhiyu,Xu Luzhou,Huang Fang,Qiu Zhixia

Funder

National Natural Science Foundation of China

Natural Science Foundation of Jiangsu Province

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology

Reference43 articles.

1. De novo lipogenesis in health and disease;Ameer;Metabolism,2014

2. Lipogenesis inhibitors: therapeutic opportunities and challenges;Batchuluun;Nat. Rev. Drug Discov.,2022

3. Metabolic drivers of non-alcoholic fatty liver disease;Bence;Mol. Metabol.,2021

4. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases;Chalasani;Hepatology,2018

5. Study on effect and molecular mechanism of Corydalis saxicola total alkaloids on nonalcoholic fatty liver mice;Chen;Drug Eval Res,2021

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Acovenosigenin A β-glucoside mediates JAK2-STAT3 signaling pathway by targeting GP130 in A549 and H460 cells based on integrative analysis of transcriptome and proteome and biological verification;Bioorganic Chemistry;2024-10

2. Quinoa Polyphenol Extract Alleviates Non-Alcoholic Fatty Liver Disease via Inhibiting Lipid Accumulation, Inflammation and Oxidative Stress;Nutrients;2024-07-15

3. Examining the Pathogenesis of MAFLD and the Medicinal Properties of Natural Products from a Metabolic Perspective;Metabolites;2024-04-12